Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guanxin V is a traditional Chinese medicine (TCM) formula used primarily for the treatment of acute myocardial infarction and related cardiovascular conditions. It exerts cardioprotective effects by alleviating apoptosis, oxidative stress damage, and fibrosis in cardiac tissue. Mechanistically, its action is associated with down-regulation of the TGF-β1 signaling pathway, which plays a key role in cardiac remodeling after injury. Preclinical studies have demonstrated that Guanxin V can reduce cell death and fibrosis while improving mitochondrial function in models of heart attack[1]. The specific herbal composition of Guanxin V is not detailed in the available sources, but it is recognized as a multi-component TCM product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guanxin V.